Sonoma Pharmaceuticals, Inc. Warrants
SNOAW
SNOAW was delisted on the 22nd of January, 2020.
1 hedge funds and large institutions have $1K invested in Sonoma Pharmaceuticals, Inc. Warrants in 2019 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 2 closing their positions.
50% less funds holding
Funds holding: 2 → 1 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.22K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $1K | +$1.22K | +95,541 | New |
|
SNOAW Hedge Fund Activity: Q3 2019 in Review
1 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Sonoma Pharmaceuticals, Inc. Warrants (SNOAW) for Q3 2019, worth a combined $1K.
Sellers outnumbered buyers: 2 funds closed out of SNOAW and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $1.22K.
- 1 institutional investor held Sonoma Pharmaceuticals, Inc. Warrants (SNOAW) as of Q3 2019, down from 2 in Q2 2019.
- Funds reported $1K of Sonoma Pharmaceuticals, Inc. Warrants stock for Q3 2019.
- 1 fund opened new Sonoma Pharmaceuticals, Inc. Warrants positions in Q3 2019 and 2 closed out, a net change of -1 holder.
- The largest Sonoma Pharmaceuticals, Inc. Warrants buyer in Q3 2019 was Susquehanna International Group, an estimated $1.22K added.
Based on aggregated 13F filings for Q3 2019.